A 53-year-old male patient. Diagnosis: Bladder cancer and TURP were established one year before starting resonant therapy (RT) using IR. Nine months before RT, intravenous urography (IVU) revealed bilateral hydronephrosis, but the patient refused surgery. Symptoms include urinary incontinence (constant dripping), urethral blockage during urination due to TURP fibrotic complications, causing pain at the base of the urethra when attempting to urinate, requiring constant urethral massage. Sometimes, there's a dull pain in the suprapubic area, lasting from a few hours to a whole day for several months.
Ultrasound before RT showed bilateral hydronephrosis and thickening of the bladder's posterior wall. RT was conducted daily for 3 weeks. Mainly RC and ZB emitters were used on the bladder. Ultrasound was repeated after 14 days - no hydronephrosis, wall thickening remains unchanged.
Urinary incontinence in the form of dripping gradually ceased, starting from the 10th day and almost completely disappeared after 20 therapy sessions over 2 months.
Pain during urination due to urethral blockage also reduced, and by his estimation, relief was about 60% (more than 50%) after the 20th session of treatment.
Absolutely no side symptoms or signs.
He feels well and did not continue treatment after 20 sessions due to the long distance (60 km), as he uses public transport and faces financial difficulties to reach the clinic.
Conclusion: RT provided symptomatic relief for the aforementioned patient with bladder cancer.
Ultrasound before RT showed bilateral hydronephrosis and thickening of the bladder's posterior wall. RT was conducted daily for 3 weeks. Mainly RC and ZB emitters were used on the bladder. Ultrasound was repeated after 14 days - no hydronephrosis, wall thickening remains unchanged.
Urinary incontinence in the form of dripping gradually ceased, starting from the 10th day and almost completely disappeared after 20 therapy sessions over 2 months.
Pain during urination due to urethral blockage also reduced, and by his estimation, relief was about 60% (more than 50%) after the 20th session of treatment.
Absolutely no side symptoms or signs.
He feels well and did not continue treatment after 20 sessions due to the long distance (60 km), as he uses public transport and faces financial difficulties to reach the clinic.
Conclusion: RT provided symptomatic relief for the aforementioned patient with bladder cancer.